Kurt von Emster
InvestorManaging Partner at Abingworth
Menlo Park, California
Writes $15M β $30M checks Β· typically $22.5M
About
Kurt von Emster joined Abingworth in January 2015 and has over 30 years of experience investing in private and public life science companies. He previously worked as a biotechnology and healthcare analyst and portfolio manager at Franklin Templeton, was a General Partner at MPM Capital, and in 2009 co-founded the US healthcare investment firm venBio, where he was most recently a Partner. He holds a Bachelor of Arts in Business and Economics.
Invests in
Biotech
Experience
- AbingworthManaging Partner, Head of Life Sciencescurrent2015 β presentMenlo Park, CA
- Iambic TherapeuticsBoard Membercurrent2023 β presentSan Diego, California, United States
- Tizona Therapeutics, Inc.Board Membercurrent2020 β presentSouth San Francisco, California, United States
- Orbus TherapeuticsBoard Membercurrent2020 β presentPalo Alto, California, United States
- SFJ Pharmaceuticals, Inc.Board Membercurrent2020 β presentPleasanton, California, United States
- Jasper TherapeuticsBoard Membercurrent2019 β presentRedwood City, California, United States
- CymaBay TherapeuticsBoard of Directors2009 β 2024Newark, California, United States
- VaxcyteChairman2015 β 2022San Carlos, California, United States
- Vera Therapeutics, Inc.Chairman2020 β 2022South San Francisco, California, United States
- Trishula Therapeutics, Inc.Board Member2020 β 2022South San Francisco, California, United States
- CRISPR TherapeuticsMember Board of Directors2015 β 2019Cambridge, MA
- Kesios TherapeuticsBoard Member2015 β 2017London Area, United Kingdom
- Cytos BiotechnologyBoard Member2012 β 2015Zurich Switzerland
- Aurinia PharmaceuticalsBoard Member2014 β 2015Victoria, BC
- venBio LLCFounding Partner2009 β 2015
- Somaxon PharmaceuticalsBoard of Directors2005 β 2013San Diego County, California, United States
- Facet BiotechBoard of Directors2009 β 2010
- MPM CapitalGeneral Partner / Portfolio Manager2000 β 2009
- Franklin Templeton InvestmentsVice President - Portfolio Management1989 β 2000
Education
- UC Santa BarbaraBachelor of Science (BS), Business and Economics1985 β 1989
Skills & more
+12 more
EntrepreneurshipCompetitive AnalysisBusiness PlanningPrivate EquityTechnology TransferManagementCommercializationLicensingExecutive ManagementCross-functional Team LeadershipM&A experienceValuation- CFA
From Kurt's professional profile.
Same school
Also attended UC Santa Barbara170
+ 164 more
Shared employers
Also worked at CRISPR Therapeutics5
Also worked at MPM Capital34
+ 28 more
Also worked at Franklin Templeton Investments30
+ 24 more
Deals Β· 3
Iambic Therapeutics, Inc.Board seat
via Abingworth Β· filed Oct 2023 Β· $110M raise
Vera TherapeuticsBoard seat
via Abingworth Β· filed Feb 2021 Β· $70.7M raise
SutroVaxBoard seat
via Abingworth Β· filed Mar 2017 Β· $60.2M raise
Attribution from SEC filings, press coverage, and firm rosters.




























